Bragar Eagel & Squire, P.C. Is Investigating Verastem, Helios, and LegalZoom and Encourages Investors to Contact the Firm

By: Bragar Eagel & Squire via GlobeNewswire

July 23, 2024 at 21:00 PM EDT

NEW YORK, July 23, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Verastem, Inc. (NASDAQ: VSTM), Helios Technologies, Inc. (NYSE: HLIO), and LegalZoom.com, Inc. (NASDAQ: LZ). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.

Verastem, Inc. (NASDAQ: VSTM)

On May 23, 2024, Verastem issued a press release “announc[ing] the initial interim safety and efficacy results from the ongoing RAMP 205 Phase 1/2 clinical trial evaluating avutometinib plus defactinib in combination with gemcitabine and Nab-paclitaxel in the first-line in patients with metastatic pancreatic cancer.” Among other items, Verastem disclosed that 12 patients experienced 19 treatment-emergent serious adverse events.

On this news, Verastem’s stock price fell $8.06 per share, or 66.17%, to close at $4.12 per share on May 24, 2024.

For more information on the Veratsem investigation go to: https://bespc.com/cases/VSTM

Helios Technologies, Inc. (NYSE: HLIO)

On July 9, 2024, Helios formally announced that Josef Matosevic, who serves as the Company’s President, Chief Executive Officer, and Director, was placed on an immediate paid leave, effective retroactively from July 1, 2024. This administrative action arose in response to allegations suggesting a potential violation of the Company’s Code of Business Conduct and Ethics. The Company has initiated an internal investigation to thoroughly examine the circumstances surrounding these allegations.

For more information on the Helios investigation go to: https://bespc.com/cases/HLIO

LegalZoom.com, Inc. (NASDAQ: LZ)

On July 9, 2024, LegalZoom issued a press release announcing that “[t]he Company is reducing its revenue expectation for the full year to a range of $675 million to $685 million and its free cash flow expectation for the full year to a range of $75 million to $85 million.” In the same press release, the Company announced that “current Chief Executive Officer Dan Wernikoff will be departing the Company, including resigning from the Board.”

On this news, multiple analysts downgraded LegalZoom, and the Company’s stock price fell $1.99 per share, or 25.35%, to close at $5.86 on July 10, 2024.

For more information on the LegalZoom investigation go to: https://bespc.com/cases/LZ

About Bragar Eagel & Squire, P.C.:

Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact Information:

Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Marion Passmore, Esq.
(212) 355-4648
investigations@bespc.com
www.bespc.com

About Us

Additional Information

Website & Technical Help

Bragar Eagel & Squire, P.C. Is Investigating Verastem, Helios, and LegalZoom and Encourages Investors to Contact the Firm

More News